Answer
Combining Softacort eye drops with cobicistat-containing medicines is expected to increase systemic corticosteroid side-effects and should be avoided unless the benefit outweighs this increased risk, in which case patients should be monitored for these effects.
Sources for this answer
- SOFTACORT 3.35 mg/ml eye drops, solution in single-dose containerThea Pharmaceuticals Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked